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NO-sensitive guanylyl cyclases (GC) are the principal
receptors for nitric oxide (NO) and convert GTP into the
second messenger cGMP. We showed that GC is prone to
tyrosine phosphorylation in COS1 cells overexpressing
the human holoenzyme. Similar results were obtained in
PC12 cells and in rat aortic tissue slices. The major phos-
phorylation site was mapped to position 192 in the regu-
latory domain of the β1  subunit. Tyrosine
phosphorylation of GC was reduced in the presence of the
inhibitors PP1 and PP2 indicating that Src-like kinases are
critically involved in phosphorylation. Moreover, co-
immunoprecipitation experiments revealed an interac-
tion between Src and GC. To further analyse the relevance
of this posttranslational modification we generated a
phospho-specific antibody raised against pTyr192. This
antibody clearly distinguishes between phosphorylated
and non-phosphorylated GC and may be a powerful tool
to analyse the subcellular localisation of the phosphor-
ylated enzyme.
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